Europe Isothermal Nucleic Acid Amplification Market
- Report Code: IS 1002
- Publish Date: Upcoming
Over the years Polymerized Chain Reaction (PCR) has been dominating the market as a standard tool detection of pathogen, blood transfusions, genetic testing, and other disorders. However, recently industry outlook has changed and shifted towards a cost-effective, rapid and reliable mode of detection for the limitations in PCR. Isothermal Nucleic Acid Amplification Technology (INAAT) addresses the demand with new developments towards point of care use.
Germany accounts for the largest market share of the European Isothermal Nucleic Acid Amplification market globally in 2013. The market is expected to grow at a CAGR of 16% from 2014 to 2019.
Analysis of market dynamics has revealed INAAT is a cost-effective technique. Increasing prevalence of infectious disease and cancer, growing demand for enhanced throughput in gene amplification, and advent of novel technologies such as Loop-Mediated Isothermal Amplification (LAMP), Nucleic Acid Sequence Based Amplification (NASBA) and Helicase Dependent Amplification (HDA) are some of the major factors responsible for market growth. The growth is attributed to its inherent features such as its ease of use, portability, or instrument-free decision.
Market segmentation and forecasting is done on the basis of technology, application and geography. The segmentation by technology comprises Helicase-dependent amplification (HDA), Loop-mediated isothermal amplification (LAMP), Nucleic acid sequence based amplification (NASBA), Single primer isothermal amplification (SPIA), Strand displacement amplification (SDA), Isothermal Nucleic Acid Amplification Instruments, Isothermal Nucleic Acid Amplification Reagents, Isothermal Nucleic Acid Amplification Services, and Transcription-mediated Amplification (TMA).
Isothermal Nucleic Acid Amplification Reagents accounts for the largest share of the European Isothermal nucleic acid amplification market and is expected to grow at a CAGR of 17.1% from 2013 to 2018. On the basis of applications the market is segmented into in vitro diagnostics, drug discovery, academics, agrigenomics, and personalized medicine. The market is further segmented and forecast on the basis of major regions, such as North America, Europe, Asia and Rest of the world (ROW).
The report provides an extensive competitive landscape of companies operating in this market. The commercial manufacture are Hologic Gen-Probe Incorporated (U.S.), BioMérieux (France), Becton Diagnostics Diagnostics (U.S.), Novartis AG (Switzerland) BioHelix (Quidel) (U.S.), Ustar Biotechnologies Ltd. (China), Meridian Bioscience, Inc. (U.S.), among others. This report also includes the market share, value chain analysis, and market metrics such as drivers, restraints and upcoming opportunities in the market.
1 Introduction
1.1 Objective of the Study
1.2 Market Segmentation & Coverage
1.3 Stakeholders
2 Research Methodology
2.1 Integrated Ecosystem of Isothermal Nucleic Acid Amplification Market
2.2 Arriving At the Isothermal Nucleic Acid Amplification Market Size
2.2.1 Top-Down Approach
2.2.2 Bottom-Up Approach
2.2.3 Demand Side Approach
2.2.4 Macro Indicator-Based Approach
2.3 Assumptions
3 Executive Summary
4 Market Overview
4.1 Introduction
4.2 Global Isothermal Nucleic Acid Amplification Market: Comparison with Parent Market
4.3 Market Drivers and Inhibitors
4.4 Key Market Dynamics
4.5 Demand Side Analysis
4.6 Vendor Side Analysis
5 Isothermal Nucleic Acid Amplification -Europe, By Application
5.1 Research Methodology
5.2 Introduction
5.3 Demand Side Analysis
5.4 Vendor Side Analysis
5.5 Isothermal Nucleic Acid Amplification in In Vitro Diagnostics
5.6 Isothermal Nucleic Acid Amplification in Drug Discovery
5.7 Isothermal Nucleic Acid Amplification in Academics
5.8 Isothermal Nucleic Acid Amplification in Agrigenomics
5.9 Isothermal Nucleic Acid Amplification in Personalized Medicine
5.10 Isothermal Nucleic Acid Amplification in Other Applications
5.11 Sneak View: Global Genomics Market, By Application
6 Isothermal Nucleic Acid Amplification - Europe, By Product
6.1 Research Methodology
6.2 Introduction
6.3 Comparison with Genomics (Parent) Market
6.4 Vendor Side Analysis
6.5 Isothermal Nucleic Acid Amplification Reagents
6.6 Isothermal Nucleic Acid Amplification Instruments
6.7 Isothermal Nucleic Acid Amplification Services
6.8 Sneak View: Genomics (Parent) Market, By Product
7 Isothermal Nucleic Acid Amplification -Europe, By Technology
7.1 Research Methodology
7.2 Introduction
7.3 Comparison with Genomics (Parent) Market
7.4 Vendor Side Analysis
7.5 Other INAAT Technologies
7.6 Helicase-dependent amplification (HDA)
7.7 Loop-mediated isothermal amplification (LAMP)
7.8 Nucleic acid sequence based amplification (NASBA)
7.9 Transcription-mediated Amplification (TMA)
7.10 Single primer isothermal amplification (SPIA)
7.11 Strand displacement amplification (SDA)
7.12 Sneak View: Genomics (Parent) Market, By Technology
8 Isothermal Nucleic Acid Amplification Market, By Geography
8.1 Research Methodology
8.2 Introduction
8.3 Vendor Side Analysis
8.4 Europe - Isothermal Nucleic Acid Amplification Market
8.4.1 Europe - Isothermal Nucleic Acid Amplification Market, By Application
8.4.2 Europe - Isothermal Nucleic Acid Amplification Market, By Product
8.5 Germany - Isothermal Nucleic Acid Amplification Market
8.5.1 Germany - Isothermal Nucleic Acid Amplification Market, By Application
8.5.2 Germany - Isothermal Nucleic Acid Amplification Market, By Product
8.6 France - Isothermal Nucleic Acid Amplification Market
8.6.1 France - Isothermal Nucleic Acid Amplification Market, By Application
8.6.2 France - Isothermal Nucleic Acid Amplification Market, By Product
8.7 U.K. - Isothermal Nucleic Acid Amplification Market
8.7.1 U.K - Isothermal Nucleic Acid Amplification Market, By Application
8.7.2 U.K - Isothermal Nucleic Acid Amplification Market, By Product
8.8 Italy - Isothermal Nucleic Acid Amplification Market
8.8.1 Italy - Isothermal Nucleic Acid Amplification Market, By Application
8.8.2 Italy - Isothermal Nucleic Acid Amplification Market, By Product
8.9 Spain - Isothermal Nucleic Acid Amplification Market
8.9.1 Spain- Isothermal Nucleic Acid Amplification Market, By Application
8.9.2 Spain- Isothermal Nucleic Acid Amplification Market, By Product
8.10 Europe - Other Geographies Isothermal Nucleic Acid Amplification Market
8.10.1 Europe - Other Geographies Isothermal Nucleic Acid Amplification Market, By Application
8.10.2 Europe - Other Geographies Isothermal Nucleic Acid Amplification Market, By Product
8.11 Sneak View: Genomics (Parents) Market, By Geography
9 Competitive Landscape
9.1 Competitive Landscape
9.1.1 Merger & Acquisition
9.1.2 Other Expansion
9.1.3 New Synergies
10 Isothermal Nucleic Acid Amplification Market, By Company
10.1 Hologic Gen-Probe Incorporated
10.1.1 Overview
10.1.2 Key Financials
10.1.3 Product and Service Offerings
10.1.4 Related Developments
10.1.5 MMM Analysis
10.2 BioMérieux
10.2.1 Overview
10.2.2 Key Financials
10.2.3 Product and Service Offerings
10.2.4 Related Developments
10.2.5 MMM Analysis
10.3 Becton Dickinson & Company
10.3.1 Overview
10.3.2 Key Financials
10.3.3 Product and Service Offerings
10.3.4 Related Developments
10.3.5 MMM Analysis
10.4 Novartis AG
10.4.1 Overview
10.4.2 Key Financials
10.4.3 Product and Service Offerings
10.4.4 Related Developments
10.4.5 MMM Analysis
10.5 BioHelix Corporation
10.5.1 Overview
10.5.2 Key Financials
10.5.3 Product and Service Offerings
10.5.4 Related Developments
10.5.5 MMM Analysis
10.6 Meridian Bioscience, Inc.
10.6.1 Overview
10.6.2 Key Financials
10.6.3 Product and Service Offerings
10.6.4 Related Developments
10.6.5 MMM Analysis
10.7 Ustar Biotechnologies Ltd.
10.7.1 Overview
10.7.2 Key Financials
10.7.3 Product and Service Offerings
10.7.4 Related Developments
10.7.5 MMM Analysis
11 APPENDIX
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
